<i>Aspergillus</i>tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study
Philipp Koehler, Saskia von Stillfried, Jorge Garcia Borrega, Frieder Fuchs, Jon Salmanton‐García, Fabian Pult, Boris Böll, Dennis A. Eichenauer, Alexander Shimabukuro‐Vornhagen, Oliver Kurzai, Peter Boor, Matthias Kochanek, Oliver A. Cornely
Abstract
<b>Comprehensive work-up is needed for COVID-19 ARDS patients, especially when suspecting invasive fungal infections. <i>Aspergillus</i> tracheobronchitis has a substantial prevalence in patients with CAPA accounting for an overall mortality of 75% in this study.</b>https://bit.ly/3uF3FZU
Topics & Concepts
ARDSAcute respiratory distressMedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCohortAspergillusIntensive care medicineLungInternal medicineVirologyOutbreakBiologyMicrobiologyInfectious disease (medical specialty)DiseaseAntifungal resistance and susceptibilityTracheal and airway disordersRespiratory and Cough-Related Research